(Q33357926)

26 July 2017

Ganciclovir therapy in cytomegalovirus (CMV) infection in immunocompetent pediatric patients (English)

1 reference

ORCID Public Data File 2021

26 July 2017

0 references

1 reference

author name string

María L Avila-Agüero

1

1 reference

26 July 2017

María M Paris

2

1 reference

26 July 2017

Wilberth Alfaro

3

1 reference

26 July 2017

Claudio R Avila-Agüero

4

1 reference

26 July 2017

Idis Faingezicht

5

1 reference

26 July 2017

1 December 2003

1 reference

International Journal of Infectious Diseases

26 July 2017

1 reference

26 July 2017

7

1 reference

26 July 2017

4

1 reference

26 July 2017

278-281

1 reference

VIROLOGIC STUDIES ON CYTOMEGALIC INCLUSION DISEASE

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990107-X

7 January 2021

Epidemiology of cytomegalovirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990107-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990107-X

1 reference

7 January 2021

Cytomegalovirus in peripheral blood leukocytes of infants with congenital or postnatal infection

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990107-X

7 January 2021

Current aspects of diagnosis and treatment of cytomegalovirus infections in infants

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990107-X

7 January 2021

Ganciclovir-resistant cytomegalovirus in organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990107-X

7 January 2021

Ganciclovir treatment of cytomegalovirus disease in immunocompromised children

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990107-X

7 January 2021

Ganciclovir therapy for severe cytomegalovirus infection in immunocompetent patients

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990107-X

7 January 2021

Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990107-X

7 January 2021

Severe cytomegalovirus infection in immunocompetent patients

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990107-X

7 January 2021

Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: a two-regimen experience.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990107-X

7 January 2021

Intractable diarrhea from cytomegalovirus enterocolitis in an immunocompetent infant

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990107-X

7 January 2021

Treatment of Rasmussen's syndrome with ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990107-X

7 January 2021

Ganciclovir therapy for cytomegalovirus-associated liver disease in immunocompetent or immunocompromised children

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2803%2990107-X

7 January 2021

10.1016/S1201-9712(03)90107-X

Identifiers

DOI

1 reference

26 July 2017

1 reference